Motufe (Fluticasone Furoate)

Fluticasone furoate, the active ingredient in Motufe, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal allergic rhinitis in adults and children. GNH USA supplies Motufe as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Motufe, a nasal corticosteroid, is used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: provides symptom relief during pollen or mold seasons. - Hay fever: improves nasal airflow and diminishes inflammatory response.

Adverse reactions may occur with any nasal corticosteroid.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Altered taste or bitter aftertaste - Throat irritation or dryness - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes such as cataracts or glaucoma - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal passages

Before initiating therapy, consider the following safety measures. - Assess for active nasal infection: avoid use until infection resolves. - Avoid in patients with known hypersensitivity to fluticasone or other corticosteroids. - Use the lowest effective dose: follow prescriber guidance. - Do not exceed recommended treatment duration without medical review. - Monitor for signs of adrenal insufficiency during long‑term therapy. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Fluticasone furoate may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic corticosteroid exposure. - Live vaccines: systemic immunosuppression can reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Concurrent intranasal medications: may increase local irritation. - Systemic corticosteroids: additive anti‑inflammatory effects may raise risk of systemic side effects. - Antifungal azoles (e.g., fluconazole): may modestly raise fluticasone levels.